Epilepsy in the elderly and its treatment;L'épilepsie du sujet âgé et son traitement

Revue de Geriatrie

Volumn 26, Issue 3, 2001, Pages 183-194

  Belmin, J ^a   Marquet, T ^a   Pariel Madjlessi, S ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Antiepileptic drugs; Elderly; Epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; VIGABATRIN;

ALZHEIMER DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COMPLEX PARTIAL SEIZURE; DEMENTIA; DRUG TOLERABILITY; EPILEPSY; HUMAN; MENTAL DISEASE; REVIEW; SIDE EFFECT;

EID: 0035066243     PISSN: 03977927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984
2. Prevalence of epilepsy in the elderly: The Rotterdam Study
3. Epidemiology and drug treatment of epilepsy in elderly people
4. Incidence of first epileptic seizures in the canton of Geneva, Switzerland
5. A survey of epileptic disorders in southwest France: Seizures in elderly patients
6. Survey of seizure disorders in the French southwest. I. Incidence of epileptic syndromes
7. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy
8. Incidence of epileptic syndromes in Rochester, Minnesota: 1980-1984
9. Incidence of epilepsy in rural Iceland: A population-based study
10. Prevalence of epilepsy in rural Iceland: A population-based study
11. Epilepsy in older adults: Causes, consequences and treatment
12. Idiopathic generalized epilepsy of late onset
13. Epilepsy in old age
14. Late-onset epilepsy
15. Seizure disorders: The changes with age
16. Reflections on the treatment of seizures in the elderly population
17. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984
18. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980
19. Epilepsy in the elderly: Incidence, social function, and disability
20. Descriptive epidemiology of epilepsy: Contributions of population-based studies from Rochester, Minnesota
21. Population-based study of seizure disorders after cerebral infarction
22. Vascular determinants of epilepsy: The Rotterdam Study
23. L'épilepsie du sujet âgé: Aspects électro-cliniques et étiologiques à partie d'une série personnelle de 100 observations
24. Dementia and adult-onset unprovoked seizures
25. Seizures and myoclonus in patients with Alzheimer's disease
26. Advanced Alzheimer's disease is a risk factor for late-onset seizures
27. The frequency of epilepsy preceding stroke. Case-control study in 230 patients
28. Epileptic seizures in elderly patients with dementia
29. 2nd. Seizures in Alzheimer's disease: Clinicopathologic study
30. A population-based study of seizures after traumatic brain injuries
31. Méningoencéphalite hérpétique chez le sujet âgé. A propos de 13 observations
32. Interictal epileptiform activity in elderly patients with epilepsy
33. Value of inpatient diagnostic CETV-EEG monitoring in the elderly
34. Usefulness of prolonged video-EEG monitoring in the elderly
35. Driving and epilepsy. A review and reappraisal
36. Pharmacokinetics of vigabatrin: Implications of creatinine clearance
37. Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research
38. Impact of valproate and phenytoin on cognitive function in elderly patients: Results of a single-blind randomized comparative study
39. Cognitive effects of anticonvulsant monotherapy in elderly patients: A placebo-controlled study
40. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy
41. Gabapentin and cognition: A double blind, dose ranging, placebo controlled study in refractory epilepsy
42. Effects of gabapentin on cognition and quality of life in patients with epilepsy
43. Vigabatrin and behaviour disorders: A retrospective survey
44. Vigabatrin and depression
45. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
46. An active-control trial of lamotrigine monotherapy for partial seizures
47. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages
48. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
49. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double- blind comparison with phenytoin
50. Lamotrigine-associated anticonvulsant hypersensitivity syndrome
51. Seizures and epilepsy in the elderly
52. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study
53. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures: International Gabapentin Monotherapy Study Group 945-77
54. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy